Skip to content

Coping With Chronic Fatigue Syndrome: Development of a Community-based Patient Education Program

Coping With Chronic Fatigue Syndrome: Development of a Community-based Patient Education Program

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01765725
Enrollment
146
Registered
2013-01-10
Start date
2011-04-30
Completion date
2016-12-31
Last updated
2017-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Fatigue Syndrome, Coping, Patient Education

Keywords

Chronic Fatigue Syndrome, Coping, Patient education

Brief summary

The aim of the study is to develop, carry out, evaluate and measure the effects of a new patient education program for patients with Chronic Fatigue Syndrome (CFS)in primary healthcare. In an randomized controlled trial design the effects of the patient education program on coping, physical functioning, fatigue, pain, acceptance, anxiety, depression, quality of life, self- efficacy, and illness perception will be compared with treatment as usual. The results of the main project will lead to the elaboration of the final patient education program that can be implemented in primary health care, as well as development of a training program for future program-conductors.

Detailed description

The project is a single blind randomized controlled trial. A total of 150 participants will be included in this study and randomly allocated to the intervention- or the control group. The 75 participants in the intervention group will be allocated to 6 groups. The control group will be offered to take part in the patient education program as soon as they have completed the last outcome evaluations.

Interventions

Patient education program, 8 meetings, every other week, 2,5 hours per meeting.

Sponsors

Stiftelsen Helse og Rehabilitering
CollaboratorOTHER
Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years and older * Meets Fukuda's research diagnostic criteria and Canadian CFS case definition * Has given oral and written informed consent * Able to tak part in the program that lasts 2,5 hours in addition to transport to and from the location for intervention.

Exclusion criteria

* Psychosis or other severe psychiatric diseases, severe personality disturbances and/or substance dependency * Pregnancy * Not being able to understand, speak and read Norwegian * Not willing to accept random assignment

Design outcomes

Primary

MeasureTime frameDescription
SF-36, subscale Physical functioning.T0: Baseline, T1: After 4 months, T2: After 10 months, T3: After 16 months.Measures change in physical functioning.
Illness Management Questionnaire (IMQ).T0: Baseline, T1: After 4 months, T2: After 10 months, T3: After 16 months.Measures change in ways of coping with CFS.

Secondary

MeasureTime frameDescription
Illness Cognition Questionnaire (ICQ)T0: Baseline, T1: After 4 months, T2: After 10 months, T3: After 16 months.Measure change in helplessness, acceptance, and perceived benefits.
The Fennell Phase Inventory (FPI)T0: Baseline, T1: After 4 months, T2: After 10 months, T3: After 16 months.Measures change in coping and progression through four phases: crisis phase, stabilization phase, resolution phase, and integration phase.
Hospital Anxiety and Depression Scale (HADS)T0: Baseline, T1: After 4 months, T2: After 10 months, T3: After 16 months.Measures change in anxiety and depression.
The SF-36 (total score and subscale role limitations due to physical limitations).T0: Baseline, T1: After 4 months, T2: After 10 months, T3: After 16 months.The SF-36 total score measures change in functional status related to health. The subscale measures change in role limitations due to physical limitations.
Brief Illness Perception Questionnaire (BIPQ)T0: Baseline, T1: After 4 months, T2: After 10 months, T3: After 16 months.Measures change in cognitive and emotional representations of illness.
Self-efficacy Scale (SE24)T0: Baseline, T1: After 4 months, T2: After 10 months, T3: After 16 months.Measures change in perceived control with respect to CFS complains.
Self-defined fatigue and pain scaleT0: Baseline, T1: After 4 months, T2: After 10 months, T3: After 16 months.Measures change in perceived fatigue and pain.
Perceived Stress Scale (PSS)- 10 itemsT0: Baseline, T1: After 4 months, T2: After 10 months, T3: After 16 months.Measures change in global perceived stress.
Fatigue Severity Scale (FSS).T0: Baseline, T1: After 4 months, T2: After 10 months, T3: After 16 months.Measures change in fatigue-related severity, symptomatology, and functional disability.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026